canthaxanthin has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadeppagari, RK; Kumaresan, N; Sanjay, KR; Umesh-Kumar, S; Venkatesh, KS; Vijayalakshmi, G | 1 |
| Bartsch, H; Celebi, O; Chang-Claude, J; Debus, J; Lilla, C; Linseisen, J; Mayer, C; Popanda, O; Schmezer, P; Woelfelschneider, A | 1 |
2 other study(ies) available for canthaxanthin and Cancer of Prostate
| Article | Year |
|---|---|
Partially saturated canthaxanthin purified from Aspergillus carbonarius induces apoptosis in prostrate cancer cell line.
Topics: Apoptosis; Aspergillus; Canthaxanthin; Cell Line, Tumor; Cell Proliferation; Growth Inhibitors; HeLa Cells; Humans; Male; Prostatic Neoplasms; Protein Binding; Receptors, Retinoic Acid; Retinoids | 2008 |
A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients.
Topics: Aged; Alcohol Drinking; beta Carotene; Body Mass Index; Canthaxanthin; DNA-Binding Proteins; Endonucleases; Haplotypes; Humans; Lutein; Lymphocytes; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Prostatic Neoplasms; Proto-Oncogene Proteins c-mdm2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Smoking; Tumor Suppressor Protein p53 | 2008 |